Abstract:Bacterial infection and local growth factor deficiency are two of the major causes of the nonunion of diabetic wounds. Antimicrobial peptides (AMPs) are believed to be alternatives to antibiotics against drug-resistant bacterial infections. 8-Bromoadenosine-3', 5'-cyclic monophosphate (8Br-cAMP) can promote cells to secrete growth factors and accelerate cell proliferation. In the present study, we constructed a hydrogel with antimicrobial peptide Jelleine-1 (J-1) and 8Br-cAMP without any other gelators or chemical crosslinking agents. The hydrogel was proved to promote the secretion of transforming growth factor-β (TGF-β) and vascular endothelial growth factor-A (VEGFA) in vitro and in vivo. Notably, it exhibited potent potential for wound healing in methicillin-resistant Staphylococcus aureus (MRSA) infected diabetic wounds. This would be attributed to the retention of AMPs and 8Br-cAMP on the wound site by the hydrogel system. In addition, the hydrogel also showed good biodegradability, proper stability, and good biocompatibility. This study would shed light on the development of carrier-free and multifunctional hydrogel for wound healing. STATEMENT OF SIGNIFICANCE: Bacterial infection and local growth factor deficiency are two of the major causes for the nonunion of refractory wounds. In the present study, an injectable carrier-free hydrogel was constructed of a natural antimicrobial peptide J-1 and 8Br-cAMP by eco-friendly physical crosslinking without any other gelators or chemical crosslinking agents. The hydrogel exhibited excellent antimicrobial activity and was proved to promote the secretion of TGF-β and VEGFA in vitro and in vivo. Correspondingly, the hydrogel showed exceptionally wound healing effects in the wound model of MRSA infected diabetic rats. This study would provide an alternative strategy or a potential hydrogel dressing for the treatment of chronic or refractory wounds.

Therapeutic Potential of Antimicrobial Peptides for Wound Healing

Antimicrobial peptides as antimicrobials for wound care management: A comprehensive review

An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections

Recent Advancement in Novel Wound Healing Therapies by Using Antimicrobial Peptides Derived from Humans and Amphibians

Therapeutic Potential of Nanocarrier Mediated Delivery of Peptides for Wound Healing: Current Status, Challenges and Future Prospective

Antimicrobial Peptides (AMPs): New Perspectives on Their Function in Dermatological Diseases

Evaluation of an antibacterial peptide‐loaded amniotic membrane/silk fibroin electrospun nanofiber in wound healing

An injectable and light curable hyaluronic acid composite gel with anti-biofilm, anti-inflammatory and pro-healing characteristics for accelerating infected wound healing

Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields

Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?

A carrier-free, dual-functional hydrogel constructed of antimicrobial peptide Jelleine-1 and 8Br-cAMP for MRSA infected diabetic wound healing

In Situ Enzyme‐Induced Self‐Assembly of Antimicrobial‐Antioxidative Peptides to Promote Wound Healing

Antimicrobial Peptide-Functionalized Mesoporous Hydrogels

Development and Challenges of Antimicrobial Peptides for Therapeutic Applications

Discovery of bioactive peptides as therapeutic agents for skin wound repair

A peptide-based pH-sensitive antibacterial hydrogel for healing drug-resistant biofilm-infected diabetic wounds

Promising anti-inflammatory activity of a novel designed anti-microbial peptide for wound healing

Recent advances in antimicrobial peptide-based therapy

From defense to offense: antimicrobial peptides as promising therapeutics for cancer

Peptides and Wound Healing: From Monomer to Combination

Advancing diabetic wound care: The role of copper-containing hydrogels